{"pmid":32463890,"title":"COVID-19 and SCA: an old friend comes to the rescue.","text":["COVID-19 and SCA: an old friend comes to the rescue.","Blood","Novelli, Enrico M","32463890"],"journal":"Blood","authors":["Novelli, Enrico M"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463890","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1182/blood.2020006442","topics":["Treatment","Prevention"],"weight":1,"_version_":1668079521450950656,"score":9.490897,"similar":[{"pmid":32475006,"title":"Coronaviridae - old friends, new enemy!","text":["Coronaviridae - old friends, new enemy!","Coronaviridae is a family of single-stranded positive enveloped RNA viruses. This article aimed to review the history of these viruses in the last 60 years since their discovery to understand what lessons can be learned from the past. A review of the PubMed database was carried out, describing taxonomy, classification, virology, genetic recombination, host adaptation, and main symptoms related to each type of virus. SARS-CoV-2 is responsible for the ongoing global pandemic, SARS-CoV and MERS-CoV were responsible for causing severe respiratory illness and regional epidemics in the past while the four other strains of CoVs (229-E OC43, NL63, and HKU1) circulate worldwide and normally only cause mild upper respiratory tract infections. Given the enormous diversity of coronavirus viruses in wildlife and their continuous evolution and adaptation to humans, future outbreaks would undoubtedly occur. Restricting or banning all trade in wild animals in wet markets would be a necessary measure to reduce future zoonotic infections.","Oral Dis","Carneiro Leao, Jair","Paula de Lima Gusmao, Teresa","Machado Zarzar, Adriana","Leao Filho, Jair Carneiro","Barkokebas Santos de Faria, Andreza","Morais Silva, Igor Henrique","Gueiros, Luiz Alcino Monteiro","Robinson, Narendran Andrew","Porter, Stephen","de Albuquerque Tavares Carvalho, Alessandra","32475006"],"abstract":["Coronaviridae is a family of single-stranded positive enveloped RNA viruses. This article aimed to review the history of these viruses in the last 60 years since their discovery to understand what lessons can be learned from the past. A review of the PubMed database was carried out, describing taxonomy, classification, virology, genetic recombination, host adaptation, and main symptoms related to each type of virus. SARS-CoV-2 is responsible for the ongoing global pandemic, SARS-CoV and MERS-CoV were responsible for causing severe respiratory illness and regional epidemics in the past while the four other strains of CoVs (229-E OC43, NL63, and HKU1) circulate worldwide and normally only cause mild upper respiratory tract infections. Given the enormous diversity of coronavirus viruses in wildlife and their continuous evolution and adaptation to humans, future outbreaks would undoubtedly occur. Restricting or banning all trade in wild animals in wet markets would be a necessary measure to reduce future zoonotic infections."],"journal":"Oral Dis","authors":["Carneiro Leao, Jair","Paula de Lima Gusmao, Teresa","Machado Zarzar, Adriana","Leao Filho, Jair Carneiro","Barkokebas Santos de Faria, Andreza","Morais Silva, Igor Henrique","Gueiros, Luiz Alcino Monteiro","Robinson, Narendran Andrew","Porter, Stephen","de Albuquerque Tavares Carvalho, Alessandra"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32475006","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/odi.13447","topics":["Mechanism"],"weight":1,"_version_":1668341932731924480,"score":54.65985},{"pmid":32417181,"title":"COVID-19: CADD to the rescue.","text":["COVID-19: CADD to the rescue.","The recent outbreak of the deadly COVID-19 disease, being caused by the novel coronavirus (SARS-CoV-2), has put the world on red alert as it keeps spreading and recording more fatalities. Research efforts are being carried out to curtail the disease from spreading as it has been declared as of global health emergency. Hence, there is an exigent need to identify and design drugs that are capable of curing the infection and hinder its continual spread across the globe. Herein, a computer-aided drug design tool known as the virtual screening method was used to screen a database of 44 million compounds to find compounds that have the potential to inhibit the surface glycoprotein responsible for virus entry and binding. The consensus scoring approach selected three compounds with promising physicochemical properties and favorable molecular interactions with the target protein. These selected compounds can undergo lead optimization to be further developed as drugs that can be used in treating the COVID-19 disease.","Virus Res","Onawole, Abdulmujeeb T","Sulaiman, Kazeem O","Kolapo, Temitope U","Akinde, Fatimo O","Adegoke, Rukayat O","32417181"],"abstract":["The recent outbreak of the deadly COVID-19 disease, being caused by the novel coronavirus (SARS-CoV-2), has put the world on red alert as it keeps spreading and recording more fatalities. Research efforts are being carried out to curtail the disease from spreading as it has been declared as of global health emergency. Hence, there is an exigent need to identify and design drugs that are capable of curing the infection and hinder its continual spread across the globe. Herein, a computer-aided drug design tool known as the virtual screening method was used to screen a database of 44 million compounds to find compounds that have the potential to inhibit the surface glycoprotein responsible for virus entry and binding. The consensus scoring approach selected three compounds with promising physicochemical properties and favorable molecular interactions with the target protein. These selected compounds can undergo lead optimization to be further developed as drugs that can be used in treating the COVID-19 disease."],"journal":"Virus Res","authors":["Onawole, Abdulmujeeb T","Sulaiman, Kazeem O","Kolapo, Temitope U","Akinde, Fatimo O","Adegoke, Rukayat O"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32417181","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.virusres.2020.198022","keywords":["cadd","covid-19","coronavirus","sars-cov-2","virtual screening","zoonotic diseases"],"topics":["Treatment"],"weight":1,"_version_":1667058206774394880,"score":49.332996},{"pmid":32282033,"title":"Initiating adjunct low dose-hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.","text":["Initiating adjunct low dose-hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.","Blood","DeBaun, Michael R","32282033"],"journal":"Blood","authors":["DeBaun, Michael R"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282033","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1182/blood.2020005992","e_drugs":["Hydroxyurea"],"topics":["Treatment"],"weight":1,"_version_":1666138491478605824,"score":47.478226},{"pmid":32469280,"title":"COVID-19: Gene Transfer to the Rescue?","text":["COVID-19: Gene Transfer to the Rescue?","Hum Gene Ther","Vandenberghe, Luk H","32469280"],"journal":"Hum Gene Ther","authors":["Vandenberghe, Luk H"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32469280","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1089/hum.2020.29125.lhv","topics":["Treatment"],"weight":1,"_version_":1668420887299227648,"score":46.785248},{"pmid":32501323,"pmcid":"PMC7252119","title":"What comes after the ICU?","text":["What comes after the ICU?","Some people with covid-19 need ventilation. Those who survive this will need a lot of physical and mental rehabilitation, finds Clare Wilson.","New Sci","Wilson, Clare","32501323"],"abstract":["Some people with covid-19 need ventilation. Those who survive this will need a lot of physical and mental rehabilitation, finds Clare Wilson."],"journal":"New Sci","authors":["Wilson, Clare"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32501323","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/S0262-4079(20)30875-7","topics":["General Info"],"weight":1,"_version_":1668804508811001856,"score":45.499195}]}